Posts by ericg
Five things: professional women’s soccer, cannabis clashes, a new IPO, migrant work permits and our woeful sports teams
Here are the 5 things you need to know in Boston business news to start your Tuesday, including professional women’s soccer, more cannabis clashes, a new IPO, migrant work permits and our woeful sports teams. Read More
Read MoreMass. business groups push feds to speed up work permits for migrants
Twenty-one organizations signed the letter to Homeland Security Secretary Alejandro Mayorkas. Together, they represent more than 10,000 employers. Read More
Read MoreEx-CBRE retail brokerage team heads to Newmark
Newmark has landed a retail brokerage team led by two veterans with expertise in Boston neighborhoods including Back Bay and the Seaport District. "I would say very broadly that the retail market in Boston is as strong as I’ve seen it in the 21 years I’ve been doing this in Boston," a group leader said.…
Read MoreTweaked college rankings sends some Mass. colleges up, down
New U.S. News & World Report rankings of the country’s best colleges has a new methodology this year — sending some Massachusetts schools rising or falling. Read More
Read MoreWith ex-Vertex leader out as CEO, biotech makes layoffs, leaves Watertown HQ
A biotech once led by a longtime Vertex Pharmaceuticals executive is making layoffs and moving headquarters. Read More
Read MoreMass. housing chief talks about migrant crisis, rent control, transfer tax and MBTA communities act
Housing and Livable Communities Secretary Ed Augustus spoke to the Business Journal about finding shelters for migrants, the upcoming bond bill and what the return of rent control could mean for the state’s housing crisis. Read More
Read MoreParatek Pharmaceuticals shareholders approve $462M buyout deal
The sale means Paratek will be going private after almost nine years as a publicly traded company. Read More
Read More2seventy bio reveals how many in Cambridge will be cut in mass layoff
2seventy bio Inc. has disclosed how many of its Cambridge employees will be cut in its 176-person layoff. Read More
Read MoreCo-founder of cancer biotech Black Diamond replaced as CEO
The board of Black Diamond Therapeutics has replaced its CEO, David Epstein, a Brandeis-trained biochemist. Read More
Read MoreCannabis regulators clash over acting chair role as lawmakers call for oversight
The Cannabis Control Commission spent the beginning of its Monday meeting embroiled in the question of who will serve as acting chair in the wake of Shannon O’Brien’s suspension. Meanwhile, lawmakers are calling for an oversight hearing. Read More
Read More